Activity value 72International Buyer&Supplier,Last transaction date:
2026-03-27
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for genesis pharma s.l. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 37 transactions, with a transaction quantity of 62614.15 and a transaction weight of 54644.15.
YearTransactionsQuantityWeight
20252612744.612744.6
20263762614.1554644.15
Bill of lading data
<
1/15
>
Trade date
2026/03/27
B/L No.
——
Suppliers
"avicenna"
Buyers
genesis pharma s.l.
POLs
——
PODs
——
Supply area
Russia
Purchas area
Uzbekistan
Weight
500.82kg
Amount
22767
Hs code
3004900002
Product tags
equipped with fixed dose drug
Product description
Медикаменты: "Карбамазепин, табл. 200мг №50 ", МНН: Carbamazepine, серии:511225, :13957 упак., Фирма произв.ПАО "АКО медицинских препаратов и изделий "Синтез". - 445,89 кг 1, 1 а 6. 0000030304717523032650000 012.2030
Expand
Trade date
2026/03/27
B/L No.
——
Suppliers
"avicenna"
Buyers
genesis pharma s.l.
POLs
——
PODs
——
Supply area
Russia
Purchas area
Uzbekistan
Weight
497.09kg
Amount
22597
Hs code
3004900002
Product tags
equipped with fixed dose drug
Product description
Медикаменты: "Карбамазепин, табл. 200мг №50 ", МНН: Carbamazepine, серии:521225, :13853 упак., Фирма произв.ПАО "АКО медицинских препаратов и изделий "Синтез". - 442,57 кг 1, 1 а 6. 0000030304717523032650001 012.2030
Expand
Trade date
2026/03/27
B/L No.
——
Suppliers
"avicenna"
Buyers
genesis pharma s.l.
POLs
——
PODs
——
Supply area
Russia
Purchas area
Uzbekistan
Weight
503.15kg
Amount
22873
Hs code
3004900002
Product tags
equipped with fixed dose drug
Product description
Медикаменты: "Карбамазепин, табл. 200мг №50 ", МНН: Carbamazepine, серии:531225, :14022 упак., Фирма произв.ПАО "АКО медицинских препаратов и изделий "Синтез". - 447,96 кг 1, 1 а 6. 0000030304717523032650002 012.2030
Expand
Trade date
2026/03/27
B/L No.
——
Suppliers
"avicenna"
Buyers
genesis pharma s.l.
POLs
——
PODs
——
Supply area
Russia
Purchas area
Uzbekistan
Weight
512.37kg
Amount
23292
Hs code
3004900002
Product tags
equipped with fixed dose drug
Product description
Медикаменты: "Карбамазепин, табл. 200мг №50 ", МНН: Carbamazepine, серии:541225, :14279 упак., Фирма произв.ПАО "АКО медицинских препаратов и изделий "Синтез". - 456,17 кг 1, 1 а 6. 0000030304717523032650003 012.2030
Expand
Trade date
2026/03/27
B/L No.
——
Suppliers
"avicenna"
Buyers
genesis pharma s.l.
POLs
——
PODs
——
Supply area
Russia
Purchas area
Uzbekistan
Weight
760.45kg
Amount
12714
Hs code
3004900002
Product tags
equipped with fixed dose drug
genesis pharma s.l. is International Buyer&Supplier,
and primarily engages in the import and export business of products such as mycophenolate,genesis,tablet.
According to the 52wmb.com global trade database, as of 2026-03-27, the company has completed 134 international trades,
with its main trading regions covering other,russia,india etc.
The core products include HS30049099 etc,
often transported via madrid etc,
and its main trading partners are интерлек,"avicenna",llc "avicenna".
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on genesis pharma s.l. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.